Inactive Instrument
Sector dividends Proto Script Pharmaceutical Corp Other OTC
Stocks
US98474L1044
Business Support Services
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 17-04-21 | Proto Script Pharmaceutical Enters Partnership with PAKmed | CI |
| 16-11-09 | Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D | CI |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.86% | 0.93% | 41.58x | 16.04x | 7.44x | 26.85x | 32.24x | 81.33B | ||
| 1.19% | 1.26% | 38.54x | - | 4.51x | 14.73x | 18.08x | 20.34B | ||
| 1.07% | 1.16% | 30.36x | 4.23x | 1.26x | 12.67x | 13.19x | 15.59B | ||
| 3.7% | 4.03% | 18.94x | 6.91x | 2.04x | 10.09x | 12.47x | 13.64B | ||
| 2.98% | 3.19% | 25.13x | 7.54x | 2.83x | 12.13x | 15.43x | 11.88B | ||
| 2.31% | 2.57% | 25.29x | 6.07x | 3.48x | 13.42x | 18.01x | 7.83B | ||
| 1.38% | 1.61% | 15.22x | 4.96x | 0.66x | 9.5x | 12.82x | 6.93B | ||
| 0.47% | 0.47% | 44.08x | 2.09x | 1.99x | 15.52x | 28.89x | 5.24B | ||
| 4.08% | 4.33% | 18.09x | 2.22x | 0.39x | 8.85x | 11.97x | 5.13B | ||
| 2.47% | 2.73% | 8.56x | 1.72x | 0.98x | 5.19x | 5.54x | 5.15B | ||
| 0.83% | 0.83% | 14.91x | - | 1.22x | 6.44x | 8.73x | 4.99B | ||
| -.--% | -.--% | 15.8x | 3.78x | 1.71x | 7.91x | 11.3x | 4.11B | ||
| 2.29% | 2.59% | 20.42x | 5.3x | 0.54x | 8.07x | 10.7x | 3.62B | ||
| 8.31% | 8.71% | 6.11x | 0.74x | 0.67x | 3.46x | 4.73x | 3.59B | ||
| 3.08% | 3.32% | 13.49x | 1.36x | 0.82x | 6.48x | 9.24x | 3.37B | ||
| 2.08% | 2.3% | 14.41x | 2.58x | 0.59x | 6.1x | 9.96x | 3.09B | ||
| Average | 2.32% | 2.5% | 21.93x | 4.68x | 1.95x | 10.46x | 13.96x | 12.24B | |
| Weighted average by Cap. | 1.63% | 1.76% | 31.62x | 10.07x | 4.34x | 17.53x | 21.59x |
- Stock Market
- Stocks
- PSCR Stock
- Stock
- Sector Proto Script Pharmaceutical Corp
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















